Key Insights

Highlights

Success Rate

75% trial completion

Treatment Research

4 treatments under study, led by Ipratropium

Research Leaders

6 sponsors active, led by Centre Hospitalier Universitaire de Besancon

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

75.0%

-11.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

75% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3
Terminated1
Unknown1

Trial Success Rate

75.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Ipratropium1
  • Nociception Level Index Monitor1
  • Anesthesia Recovery After Intracranial Surgery1
  • Albuterol1

Active Sponsors

  • Centre Hospitalier Universitaire de Besancon1
  • Haseki Training and Research Hospital1
  • Hospital Nord1
  • University Hospital, Geneva1
  • Beijing Municipal Administration of Hospitals1

Top Investigators

Related Conditions

  • Pain Chronic1
  • Thoracotomy1
  • Anesthesia General1
  • Postoperative Care1
  • Neurosurgery1

Activity Timeline